Your browser doesn't support javascript.
loading
Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression.
Nason, Shelly R; Kim, Teayoun; Antipenko, Jessica P; Finan, Brian; DiMarchi, Richard; Hunter, Chad S; Habegger, Kirk M.
Affiliation
  • Nason SR; Comprehensive Diabetes Center and Department of Medicine - Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama.
  • Kim T; Comprehensive Diabetes Center and Department of Medicine - Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama.
  • Antipenko JP; Comprehensive Diabetes Center and Department of Medicine - Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama.
  • Finan B; Novo Nordisk Research Center, Indianapolis, IN.
  • DiMarchi R; Novo Nordisk Research Center, Indianapolis, IN.
  • Hunter CS; Department of Chemistry, Indiana University, Bloomington, IN.
  • Habegger KM; Comprehensive Diabetes Center and Department of Medicine - Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama.
Endocrinology ; 161(1)2020 01 01.
Article in En | MEDLINE | ID: mdl-31673703

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Gene Expression Regulation / Receptors, Glucagon / Lipid Metabolism / Receptors, Leptin / Fatty Liver Type of study: Prognostic_studies Limits: Animals Language: En Journal: Endocrinology Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Gene Expression Regulation / Receptors, Glucagon / Lipid Metabolism / Receptors, Leptin / Fatty Liver Type of study: Prognostic_studies Limits: Animals Language: En Journal: Endocrinology Year: 2020 Document type: Article